GB201411429D0 - Methods for monitoring treatment response and relapse in ovarian cancer - Google Patents
Methods for monitoring treatment response and relapse in ovarian cancerInfo
- Publication number
- GB201411429D0 GB201411429D0 GB201411429A GB201411429A GB201411429D0 GB 201411429 D0 GB201411429 D0 GB 201411429D0 GB 201411429 A GB201411429 A GB 201411429A GB 201411429 A GB201411429 A GB 201411429A GB 201411429 D0 GB201411429 D0 GB 201411429D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- relapse
- methods
- ovarian cancer
- treatment response
- monitoring treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1311385.7A GB201311385D0 (en) | 2013-06-26 | 2013-06-26 | Method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB201411429D0 true GB201411429D0 (en) | 2014-08-13 |
| GB2519830A GB2519830A (en) | 2015-05-06 |
Family
ID=48999008
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1311385.7A Ceased GB201311385D0 (en) | 2013-06-26 | 2013-06-26 | Method |
| GB1411429.2A Withdrawn GB2519830A (en) | 2013-06-26 | 2014-06-26 | Methods for monitoring treatment response and relapse in ovarian cancer |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1311385.7A Ceased GB201311385D0 (en) | 2013-06-26 | 2013-06-26 | Method |
Country Status (2)
| Country | Link |
|---|---|
| GB (2) | GB201311385D0 (en) |
| WO (1) | WO2014207170A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201311385D0 (en) * | 2013-06-26 | 2013-08-14 | Afg Technologies S R L | Method |
| RU2637399C1 (en) * | 2017-02-02 | 2017-12-04 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр" Российской академии наук ("Томский НИМЦ") | Method for prediction of probability of possible execution of optimum cytoreductive operation in patients with disseminated forms of ovarian cancer |
| RU2658047C1 (en) * | 2017-05-11 | 2018-06-19 | Государственное автономное учреждение здравоохранения "Республиканский клинический онкологический диспансер Министерства здравоохранения Республики Татарстан" | Method of estimation of risk of recurrency of ovarian cancer |
| RU2671409C2 (en) * | 2017-12-05 | 2018-10-31 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) | Method for prediction of cytoreductive surgery volume in patients with advanced ovarian cancer after completion of third course of neoadjuvant chemotherapy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994021686A1 (en) | 1993-03-19 | 1994-09-29 | Northern Sydney Area Health Service | Papp-a, its immunodetection and uses |
| US7462458B2 (en) * | 2002-05-15 | 2008-12-09 | Mayo Foundation For Medical Education And Research | Methods of detecting ovarian neoplasia |
| GB201311385D0 (en) * | 2013-06-26 | 2013-08-14 | Afg Technologies S R L | Method |
-
2013
- 2013-06-26 GB GBGB1311385.7A patent/GB201311385D0/en not_active Ceased
-
2014
- 2014-06-26 GB GB1411429.2A patent/GB2519830A/en not_active Withdrawn
- 2014-06-26 WO PCT/EP2014/063629 patent/WO2014207170A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| GB2519830A (en) | 2015-05-06 |
| WO2014207170A1 (en) | 2014-12-31 |
| GB201311385D0 (en) | 2013-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201309568D0 (en) | Methods and apparatus | |
| PT3095044T (en) | Block mining methods and apparatus | |
| IL244510A0 (en) | Cancer biomarkers and uses thereof | |
| GB201310910D0 (en) | The use of phytocannabinoids in the treatment of ovarian carcinoma | |
| SG11201603050TA (en) | Methods for treating cancers | |
| EP2988208A4 (en) | Application sharing method and device | |
| IL244353A0 (en) | Compounds and use for treating cancer | |
| GB201604534D0 (en) | Nucleic-acid-sequence determination device and nucleic-acid-sequence determination method | |
| GB201317429D0 (en) | Spectroscopy apparatus and method | |
| EP2946614A4 (en) | Methods and apparatus | |
| LT3065828T (en) | Methods and materials for treating hematological malignancies | |
| PL3071192T3 (en) | Curcuphenol compound for use in treating cancer | |
| HUE048625T2 (en) | Methods for treating cancer | |
| GB201411429D0 (en) | Methods for monitoring treatment response and relapse in ovarian cancer | |
| GB201301728D0 (en) | Telcommunications apparatus and methods | |
| PL2986429T3 (en) | Device and process for profils edge-banding | |
| GB2519734B (en) | Apparatus and Methods | |
| GB201316737D0 (en) | Apparatus and Methods | |
| GB201307787D0 (en) | Methods and Apparatus | |
| GB201316896D0 (en) | Processing Methods and cassette | |
| AP2015008760A0 (en) | Hydrocarbon-producing apparatus and hydrocarbon-producing method | |
| GB2519829B (en) | Methods for monitoring treatment response and relapse in breast cancer | |
| IL246185A0 (en) | Composihons and methods for treating disregulatel systems | |
| GB2537485B (en) | Apparatus and methods for selectively treating production zones | |
| GB2532359B (en) | Process and apparatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |